Pennant Group (PNTG) Raised Revenue Guidance, Is The Stock Still Cheap?
Pennant Group (PNTG) has drawn fresh investor attention after reporting second quarter 2026 results with higher sales and net income year on year, along with updated full year revenue guidance in early August.
See our latest analysis for Pennant Group.
The recent earnings beat and higher full year revenue guidance have come alongside a 40.14% year to date share price return and a 232.20% three year total shareholder return, although short term share price momentum has eased with the stock down over the past month.
If Pennant Group’s results have you rethinking where growth might come from next, it could be worth scanning other healthcare AI opportunities through the 43 healthcare AI stocks
The recent run in Pennant Group stock and the gap between the US$39 share price and various fair value estimates put the focus squarely on one issue: Where does a sensible valuation range actually sit now?
Most Popular Narrative: 10.3% Undervalued
The most followed Pennant Group narrative currently places fair value at $43.50, above the last close at $39.00. This frames the stock as modestly discounted based on that view.
The accelerating demographic shift of an aging U.S. population is leading to rising demand for home health, hospice, and senior living services, as evidenced by Pennant's strong organic and acquisition-driven volume growth and robust occupancy/pricing trends in senior living. This ongoing demographic wave is likely to continue expanding Pennant's addressable market, supporting durable, long-term revenue growth.
Curious how this aging population theme turns into a specific dollar figure for Pennant Group? The narrative leans on compounded revenue estimates, rising margins, and a future earnings multiple that needs to compress yet still support that higher fair value.
Result: Fair Value of $43.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Pennant Group’s story is still exposed to policy and cost shocks, particularly any tougher Medicare or Medicaid reimbursement, as well as persistent wage and staffing pressure.
Find out about the key risks to this Pennant Group narrative.
Another View On Pennant Group’s Valuation
While the most followed Pennant Group narrative points to a fair value of $43.50 and a modest 10.3% discount, the SWS DCF model paints a much stronger value gap. On that view, Pennant Group trades at $39 against an estimated future cash flow value of $82.70, which frames the stock as heavily undervalued instead of just mildly discounted. Which version of “undervalued” do you trust more, the narrative based on earnings multiples or the cash flow model that leans on long run assumptions about the business?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
If this mix of optimism and concern around Pennant Group feels familiar, consider taking a closer look now so you can judge the balance of risks and rewards for yourself. You can start with 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Pennant Group?
If Pennant Group has sharpened your focus on where to put your next dollar, do not stop here. Fresh ideas often come from comparing quality opportunities side by side.
- Target resilient companies by checking out 83 resilient stocks with low risk scores that might help steady your portfolio when markets get choppy.
- Hunt for value by reviewing screener containing 21 high quality undiscovered gems that many investors may not be watching yet but still show solid fundamentals.
- Strengthen your core holdings by scanning the solid balance sheet and fundamentals stocks screener (48 results) so you can focus on businesses backed by healthier finances.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com